Publication:
Is it justifiable to move the grade-1 Ki67 index cut-off from 3% to 5% for pancreatic neuroendocrine tumors as has been proposed? The cases that fall to 3-5% category have clinicopathologic characteristics closer to those > 5%

Simple item page
dc.contributor.coauthorReid, Michelle
dc.contributor.coauthorBalci, Serdar
dc.contributor.coauthorBagci, Pelin
dc.contributor.coauthorSaka, Burcu
dc.contributor.coauthorPehlivanoglu, Burcin
dc.contributor.coauthorSeven, Ipek Erbarut
dc.contributor.coauthorBasturk, Olca
dc.contributor.departmentN/A
dc.contributor.kuauthorAdsay, Nazmi Volkan
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.contributor.yokid286248
dc.date.accessioned2024-11-10T00:00:09Z
dc.date.issued2020
dc.description.abstractN/A
dc.description.indexedbyWoS
dc.description.issueSUPPL 2
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume33
dc.identifier.doiN/A
dc.identifier.eissn1530-0285
dc.identifier.issn0893-3952
dc.identifier.quartileQ1
dc.identifier.urihttps://www.nature.com/articles/s41379-020-0482-7.pdf
dc.identifier.urihttps://hdl.handle.net/20.500.14288/15760
dc.keywordsGrade-1 Ki67 index
dc.keywordsPancreatic neuroendocrine tumors
dc.languageEnglish
dc.publisherSpringer
dc.sourceModern Pathology
dc.subjectPathology
dc.titleIs it justifiable to move the grade-1 Ki67 index cut-off from 3% to 5% for pancreatic neuroendocrine tumors as has been proposed? The cases that fall to 3-5% category have clinicopathologic characteristics closer to those > 5%
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.authorid0000-0002-1308-3701
local.contributor.kuauthorAdsay, Nazmi Volkan

Files

Collections

Publications without Fulltext